RESOLUTION ON DEVELOPING A TIMELY AND EFFECTIVE LEGISLATIVE, REGULATORY AND ADMINISTRATIVE RESPONSE TO THE EMERGENCE OF NEW PSYCHOACTIVE SUBSTANCES 1. Mindful that the international drug problem continues to constitute a serious threat to the health, safety and well-being of humanity as a whole, 2. Recalling the 2010 Astana Commemorative Declaration, in which the Heads of State and Government of OSCE participating States recognized the need to achieve a greater unity of purpose and action in facing emerging transnational threats, 3. Recognizing the leading role of the United Nations in the resolution of the international drug problem, 4. Bearing in mind the Outcome Document of the United Nations General Assembly Special Session on the World Drug Problem, held on 19-21 April 2016 in New York, which addressed, inter alia, the problem of emerging and persistent challenges and threats, including new psychoactive substances, 5. Recalling the relevant resolutions of the United Nations Commission on Narcotic Drugs that refer to the problem of new psychoactive substances, 6. Recalling the 2015 Ministerial Council Declaration of the Ministers for Foreign Affairs on the OSCE activities in support of global efforts in tackling the world drug problem (MC.DOC/2/15), 7. Also recalling Permanent Council Decision No. 1048 on the OSCE Concept for Combating the Threat of Illicit Drugs and the Diversion of Chemical Precursors, Permanent Council Decision No. 1049 on the OSCE Strategic Framework for PoliceRelated Activities, and other relevant OSCE documents adopted to combat illicit drugs, and noting the OSCE executive structures’ efforts to implement them in accordance with their respective mandates, 8. Bearing in mind the outcome of the conferences held across the OSCE on combating the threat of illicit drugs, including new psychoactive substances, and the diversion of chemical precursors, as well as the relevant regional and sub-regional working groups of experts, OSCE training events, and awareness-raising and capacity-building initiatives, 9. Recognizing the adverse effects on the population and the risks to its health and safety arising from new psychoactive substances, 10. Recognizing the gaps in knowledge about the harm to the health and safety of the population caused by new psychoactive substances, 40